...
首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.
【24h】

Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.

机译:氟班色林(Flibanserin)是一种旨在治疗绝经前妇女性欲减退的药物,会影响雌性大鼠的自发运动活动和脑神经化学。

获取原文
获取原文并翻译 | 示例
           

摘要

Flibanserin, a 5-HT(1A) receptor agonist and 5-HT(2A) receptor antagonist, is being developed for the treatment of hypoactive sexual desire disorder (HSDD) in pre-menopausal women. Here, we investigated the effects of acute administration of flibanserin (15 and 45 mg/kg, p.o.) and the selective 5-HT(1A) receptor agonist (+)-8-OH-DPAT (1 mg/kg, i.p.) on neurotransmitter levels in brain areas of female rats. Specifically, levels of dopamine (DA) and serotonin (5-HT) and neurotransmitter metabolites were examined in prefrontal cortex (PFC), nucleus accumbens, hypothalamus and brain stem using high performance liquid chromatography coupled to electrochemical detection. In addition, spontaneous motor activity was determined in an automated motor activity system. Flibanserin (45 mg/kg) but not (+)-8-OH-DPAT significantly reduced motor activity, when compared to vehicle controls. Specifically, the DA turnover was significantly increased (279%) in the PFC after flibanserin treatment but less pronounced (159%) after 8-OH-DPAT administration. Serotonin tissue levels were not altered in any of the investigated brain regions upon flibanserin treatment. However, flibanserin produced a significant decrease of the major serotonin metabolite 5-hydroxyindoleacetic acid and 5-HT turnover in the PFC, nucleus accumbens, hypothalamus and brain stem similar to (+)-8-OH-DPAT. In conclusion, the present study indicates that flibanserin is able to modulate dopaminergic and serotonergic activity in distinct brain areas. The observed effects in the PFC on dopaminergic markers are different from those induced by (+)-8-OH-DPAT and may contribute to its therapeutic efficacy in HSDD. The effects of flibanserin on spontaneous motor behaviour are in agreement with its receptor profile and underscore that flibanserin is devoid of any locomotor hyperactivity inducing properties.
机译:氟班色林是一种5-HT(1A)受体激动剂和5-HT(2A)受体拮抗剂,目前正在开发,用于治疗绝经前妇女的性欲减退(HSDD)。在这里,我们调查了氟班色林(15和45 mg / kg,口服)和选择性5-HT(1A)受体激动剂(+)-8-OH-DPAT(1 mg / kg,ip)急性给药的作用雌性大鼠大脑区域的神经递质水平。具体而言,使用高效液相色谱结合电化学检测,检查了额叶前额叶(PFC),伏隔核,下丘脑和脑干中的多巴胺(DA)和5-羟色胺(5-HT)和神经递质代谢产物的水平。另外,在自动运动活动系统中确定了自发运动活动。与媒介物对照相比,氟班色林(45 mg / kg)但不降低(+)-8-OH-DPAT。具体而言,在氟班色林治疗后,PFC中的DA转换显着增加(279%),但在施用8-OH-DPAT后则不明显(159%)。氟班色林治疗后,任何研究的脑区域中血清素组织水平均未改变。然而,氟班色林使PFC,伏隔核,下丘脑和脑干中的主要血清素代谢物5-羟吲哚乙酸和5-HT转换量显着减少,类似于(+)-8-OH-DPAT。总之,本研究表明,氟班色林能够调节不同脑区的多巴胺能和血清素能活动。在PFC中观察到的对多巴胺能标志物的作用不同于(+)-8-OH-DPAT诱导的作用,并且可能有助于其在HSDD中的治疗功效。氟班色林对自发运动行为的影响与其受体特征一致,并强调氟班色林没有任何诱导运动亢进的特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号